Mezzanine/Pre-IPO Private Placements

Sunday, July 19, 2020
9:00 a.m. – 10:00 a.m. EDT
4:00 p.m. – 5:00 p.m. Israel Time
Register here

Join Mayer Brown and PwC for a webinar on Life Sciences IPOs.  Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our

Kevin Gsell, Head of Legal Solutions & Partnerships at Nasdaq Private Markets, joined our annual session on late stage or pre-IPO private placements earlier this week.  As discussed during our session, as companies choose to remain private longer, and defer liquidity events, early investors and employees require liquidity opportunities.  In fact, in many cases, the

Professor Anat Alon-Beck from the School of Law at Case Western Reserve University joined our annual conference on Late Stage Private Placements earlier this week.  Prof. Beck spoke about the unicorn phenomenon, valuation concerns relating to unicorns and the new investors that have fueled the growth of unicorns.  Prof. Beck’s slides may be accessed here

During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a recent CB Insights report, healthcare companies raised $14.6 billion this past quarter in 1,156 deals. Deal volume decreased 6% quarter-over-quarter. The inverse

Tuesday, January 28, 2020
9:00 a.m. – 9:30 a.m. Registration/Breakfast
9:30 a.m. – 11:00 a.m. Program

To register, please click here.

While the IPO market remains active, companies continue to raise large sums of private capital through late stage private placements, with companies now taking an average of seven years to IPO. However, late stage

The financing environment for startup companies in the technology sector has changed substantially over the last few years. As evidenced by findings in CB Insights’ latest report, The 2020 Tech IPO Pipeline, tech companies have raised more funding than ever before by accessing the private venture markets. These startups reach unicorn status well before

The third quarter of 2019 saw a slight decrease in venture private capital funding levels according to PwC and CB Insights’ recently published MoneyTree report. Approximately $25.9 billion was raised across 1,304 deals, bringing total capital raised in 2019 to $83 billion.

Staying private longer. Companies have taken advantage of raising large amounts of

In a recent briefing, CB Insights reported increased funding in the healthcare sector for the first half of 2019 with $26.9 billion invested in healthcare companies across 2,258 deals globally. While promising, funding for full year 2019 is not projected to surpass the $58.5 billion raised by healthcare companies in 2018.  The number of late-stage

A recent research report published by Goldman Sachs reviews private market value creation compared to public market creation.  Echoing the trends noted in other publications, the report notes the increasingly important role of venture capital as an asset class.  The growth in venture funding has contributed to companies remaining private longer.  The report notes that